13D Filing: Glaxosmithkline Plc and Innoviva Inc. (NASDAQ:INVA)

1.

NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

GlaxoSmithKline plc

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) ☐
(b) ☐

3.

SEC USE ONLY

4.

SOURCE OF FUNDS (see instructions)
 
WC

5.

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ☐

6.

CITIZENSHIP OR PLACE OF ORGANIZATION
 
England and Wales

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

7.

SOLE VOTING POWER
 
32,005,260 shares of Common Stock (See Items 5(a) and 5(b))

8.

SHARED VOTING POWER
 
-0-

9.

SOLE DISPOSITIVE POWER
 
32,005,260 shares of Common Stock (See Items 5(a) and 5(b))

10.

SHARED DISPOSITIVE POWER
 
-0-

11.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

32,005,260 shares of Common Stock (See Item 5(a)) ⁽¹⁾

12.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions) ☐

13.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

29.3% of the shares of Common Stock (See Item 5(a)) ⁽²⁾

14.

TYPE OF REPORTING PERSON (see instructions)

CO

Footnotes: